Does LOMITAPIDE Cause Intentional product use issue? 29 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Intentional product use issue have been filed in association with LOMITAPIDE (Juxtapid). This represents 0.8% of all adverse event reports for LOMITAPIDE.
29
Reports of Intentional product use issue with LOMITAPIDE
0.8%
of all LOMITAPIDE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Intentional product use issue From LOMITAPIDE?
Of the 29 reports, 6 (20.7%) required hospitalization, and 1 (3.4%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMITAPIDE. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does LOMITAPIDE Cause?
Diarrhoea (1,071)
Therapy cessation (828)
Weight decreased (828)
Nausea (567)
Abdominal pain upper (280)
Flatulence (244)
Abdominal discomfort (228)
Vomiting (211)
Off label use (206)
Fatigue (200)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which LOMITAPIDE Alternatives Have Lower Intentional product use issue Risk?
LOMITAPIDE vs LOMUSTINE
LOMITAPIDE vs LONAPEGSOMATROPIN-TCGD
LOMITAPIDE vs LONCASTUXIMAB TESIRINE-LPYL
LOMITAPIDE vs LOPERAMIDE
LOMITAPIDE vs LOPINAVIR